IDiyas

For the Inventor, By the Inventor

Osaka, Japan

Michiyuki Sendai

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 106(Granted Patents)


Location History:

  • Osaka, JP (1978 - 1995)
  • Suita, JP (1988 - 1995)

Company Filing History:

goldMedal12 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1978-1995

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5459260 - Tricyclic or tetracyclic carbapenem compounds, their production and use (1995-10-17),
2. 5438053 - Cephem compounds compositions and method (1995-08-01),
3. 5393751 - Tricyclic carbapenem compounds (1995-02-28),
4. 4971963 - Cephem compounds, and use (1990-11-20),
5. 4833134 - Cephem compounds (1989-05-23),
6. 4794108 - 1-carboxymethoxy acetidinones and their production (1988-12-27),
7. 4323676 - Process for preparing cephalosporins (1982-04-06),
8. 4308381 - Cephem compounds (1981-12-29),
9. 4245088 - Novel 3-acyloxymethyl-cephem compounds useful as intermediates for (1981-01-13),
10. 4224441 - Derivatives of 7-aminocephalosporanic acid (1980-09-23),
11. 4166178 - 3-Acyloxymethyl-cephem compounds (1979-08-28),
12. 4122258 - Process for producing desacetoxycephalosporin derivatives by heating a (1978-10-24),

Title: The Innovative Contributions of Inventor Michiyuki Sendai

Introduction

Michiyuki Sendai, an accomplished inventor based in Osaka, Japan, has made significant strides in the field of medicinal chemistry. With a portfolio of 12 patents, he has dedicated his career to developing novel compounds that hold promise for the treatment of bacterial infections. His insights and innovations in the pharmaceutical domain have been instrumental in advancing therapeutic options.

Latest Patents

Sendai's recent patents highlight his focus on carbapenem and cephem compounds. One of his latest inventions includes tricyclic or tetracyclic carbapenem compounds and their production methods, offering valuable antibacterial agents. The specific formulations, which emphasize complex molecular structures, illustrate his commitment to improving medicinal efficacy. Furthermore, he has developed novel cephem compounds that exhibit unique characteristics, showcasing his innovative approach to chemical synthesis and application.

Career Highlights

Throughout his career, Michiyuki Sendai has been associated with Takeda Chemical Industries, Inc., a company renowned for its contributions to the pharmaceutical industry. His work has not only enhanced Takeda's portfolio but has also set new standards for antibacterial agents, addressing the critical need for effective treatments against resistant bacterial strains.

Collaborations

Sendai has collaborated with esteemed colleagues, including Susumu Tsushima and Mitsuru Shiraishi. These partnerships have been pivotal in fostering a creative environment that encourages innovative solutions within the realm of pharmaceutical development.

Conclusion

Michiyuki Sendai's contributions to the field of medicinal chemistry are noteworthy. His extensive patent portfolio and ongoing collaborations underscore his dedication to innovation in healthcare. As his work continues to evolve, it promises to make a lasting impact on the treatment of bacterial infections, solidifying his legacy as a prominent inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…